ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 697 • 2017 ACR/ARHP Annual Meeting

    Does Erythrocyte Sedimentation Rate Reflect and Discriminate Flare from Infection in Systemic Lupus Erythematosus? Correlation with Clinical and Laboratory Parameters of Disease Activity

    Valentin S. Schäfer1, Katharina Weiss2, Andreas Krause2 and Wolfgang A. Schmidt3, 1Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 2Medical Centre for Rheumatology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 3Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

    Background/Purpose: ESR is applied for monitoring disease activity in SLE. It is known to be influenced by age and infections. We aimed at evaluating how…
  • Abstract Number: 698 • 2017 ACR/ARHP Annual Meeting

    Selected Nailfold Videocapillaroscopy Changes Are Linked to SLE Onset in a Cohort of Uctd Subjects

    Marianna Meroni1, Carmen Pizzorni2, Alberto Sulli1, Paola Rossi3, Paolo Stobbione3 and Maurizio Cutolo4, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genova, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino, Genoa, Italy, Genoa, Italy, 3Rheumatology Unit, Internal Medicine Department - A.O. S.S. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy, 4Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy

    Background/Purpose: Nailfold capillaroscopy (NVC) is a useful, non-invasive, reproducible and cost-effective diagnostic tool, able to assess the shape of capillaries in the nailfold bed. According…
  • Abstract Number: 699 • 2017 ACR/ARHP Annual Meeting

    Impact of Anti-RBP Antibodies on Disease Activity and Quality-of-Life in Immunosuppressant Naive Systemic Lupus Erythematosus

    Rene Bermea1, Tammy Utset2 and Kichul Ko3, 1Medicine, University of Chicago, Chicago, IL, 2Medicine, Section of Rheumatology, University of Chicago, Chicago, IL, 3Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL

    Background/Purpose: There is a lack of phenotypic data on SLE patients who have never been on immunosuppressive therapy. Anti-RNA binding protein (anti-RBP) antibodies (anti-Smith, anti-RNP,…
  • Abstract Number: 700 • 2017 ACR/ARHP Annual Meeting

    Variability in Method of Testing for Antinuclear Antibodies (ANA): A Survey of Participants in the College of American Pathologist’s (CAP) Proficiency Testing Program

    Stanley J. Naides1, Jonathan Genzen2, Gyorgy Abel3, Christine Bashleben4 and Mohammad Qasim Ansari5, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2ARUP Laboratories Inc, Salt Lake City, UT, 3Department of Pathology and Laboratory Medicine, Lahey Clinic Burlington, Burlington, VT, 4College of American Pathologists, Northfield, IL, 5Department of Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, OH

    Background/Purpose: A 2010 American College of Rheumatology position paper designated indirect immunofluorescence assay (IFA) on HEp-2 cells the “gold standard” for ANA testing and that…
  • Abstract Number: 701 • 2017 ACR/ARHP Annual Meeting

    Variability in ICAP (International Consensus on ANA Patterns) Pattern Reporting in Testing for Antinuclear Antibodies (ANA) By Indirect Immunofluorescence Assay (IFA)

    Stanley J. Naides1, Jonathan Genzen2, Gyorgy Abel3, Christine Bashleben4 and Mohammad Qasim Ansari5, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2ARUP Laboratories Inc, Salt Lake City, UT, 3Department of Pathology and Laboratory Medicine, Lahey Clinic Burlington, Burlington, VT, 4College of American Pathologists, Northfield, IL, 5Department of Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, OH

    Background/Purpose: ANA IFA pattern may guide clinical evaluation by directing specific antibody testing. ICAP has defined consensus ANA IFA patterns and the level of competency…
  • Abstract Number: 702 • 2017 ACR/ARHP Annual Meeting

    Positive Direct Coombs’ Test in the Absence of Hemolytic Anemia Predicts High Disease Activity and Poor Renal Response in Systemic Lupus Erythematosus

    Hironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, Yukiko Takakuwa and Kimito Kawahata, Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan

    Background/Purpose: Direct Coombs' test in the absence of hemolytic anemia was newly included in the immunologic criterion of the SLICC/ACR 2012 criteria for SLE. Since…
  • Abstract Number: 703 • 2017 ACR/ARHP Annual Meeting

    Clinical Value of Autoantibodies for Lupus Myelitis and Its Subtypes: A Systematic Review

    Hiroshi Oiwa1, Akira Kuriyama2, Tomoyasu Matsubara3 and Eiji Sugiyama4, 1Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, 2General Medicine, Kurashiki Central Hospital, Kurashiki, Japan, 3Neurology, Hiroshima University Hospital, Hiroshima, Japan, 4Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

    Background/Purpose: We conducted a systematic review to investigate the clinical value of clinical characteristics and autoantibodies, especially lupus-specific antibodies, for lupus myelitis and its subtypes.…
  • Abstract Number: 704 • 2017 ACR/ARHP Annual Meeting

    Detection of dsDNA Antibodies By New Fluoroimmunoassay with Comparable Diagnostic Sensitivity and Specificity to Farr-Ria

    Katja Lakota1,2, Tanja Kveder2, Tinka Svec2, Polona Žigon2, Ales Ambrozic3, Borut Božič2,4, Matija Tomšič2,5, Saša Čučnik2,4 and Snezna Sodin Semrl1,2, 1Faculty of Mathematics, Natural Science and Information Technology, University of Primorska, Koper, Slovenia, 2Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3Department of Rheumatology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia, 4Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia, 5University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia

    Background/Purpose: Antibodies against double-stranded deoxyribonucleic acid (anti-dsDNA) are a useful and valuable serological marker for diagnosis of systemic lupus erythematosus (SLE). Studies suggest strong correlation…
  • Abstract Number: 705 • 2017 ACR/ARHP Annual Meeting

    Optimization of a Cost-Effective Diagnostic ANA Algorithm

    Mathieu Cauchie1, Bert Vander Cruyssen2, Stefanie Van den Bremt3, Muriel Stubbe4, Xavier Bossuyt5 and Lieve Van Hoovels3, 1OLV Hospital, Aalst, Belgium, 2Rheumatology, OLV hospital, Aalst, Belgium, 3Laboratory medicine, OLV Hospital, Aalst, Belgium, 4Rheumatology, OLV Hospital, Aalst, Belgium, 5Laboratory medicine, University Hospital Leuven, Leuven, Belgium

    Background/Purpose: Due to the poor specificity of the anti-nuclear antibodies (ANA) indirect immunofluorescence (IIF) assay, enhanced by the huge increase in ANA requests by non-rheumatologists,…
  • Abstract Number: 706 • 2017 ACR/ARHP Annual Meeting

    Elevated Erythrocyte Sedimentation Rate Among Obese Patients with SLE- Not Always a Marker of Disease Activity

    George Stojan1, Erik Barr2 and Michelle Petri3, 1Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 3Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD

    Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28 and…
  • Abstract Number: 707 • 2017 ACR/ARHP Annual Meeting

    Distinctive Features of Positive Anti-Cell Antibody Tests on HEp-2 Cells (HEp-2-ANA) in Patients with Non-Autoimmune Diseases

    Renan Agustinelli1, Sílvia H. Rodrigues2, Mônica Prado3, Henrique Mariz4 and Luis Eduardo C. Andrade5,6, 1Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, São Paulo, Brazil, 2Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil, 3Rheumatology Division, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 4Internal Medicine Department, Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, 5Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil, 6Immunology Division, Fleury Medicine and Health, São Paulo, Brazil

    Background/Purpose: The indirect immunofluorescence (IIF) test for anti-cell or antinuclear (ANA) antibodies on HEp-2 cells (HEp-2-ANA) is considered the gold standard method for ANA detection.…
  • Abstract Number: 708 • 2017 ACR/ARHP Annual Meeting

    Anti-RNP/Sm Antibodies Plus Lupus Anticoagulant As Risk Factor for Thrombosis in Patients with Systemic Lupus Erythematosus

    Mari Carmen Zamora-Medina1, Andrea Hinojosa-Azaola2, Carlos Núñez-Álvarez3 and Juanita Romero-Diaz4, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutricion S.Z., Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion S.Z., Mexico city, Mexico, 4Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico

    Background/Purpose: In a previous study, we identify a potential role of anti-RNP/Sm in combination with LA as risk factor for thrombosis. We aimed to validate…
  • Abstract Number: 709 • 2017 ACR/ARHP Annual Meeting

    Characteristics of Cardiac Diseases in Systemic Lupus Erythematosus and Risk Factors of Different Echocardiographic Features

    Nevin Hammam1,2, Mona H EL zohri3 and Alaa A A Mohamed1, 1Rheumatology, Rehabilitation and Physical medicine, Assiut University, Faculty of Medicine, Assiut, Egypt, 2Department of Physical therapy, University of Alberta, Edmonton, AB, Canada, 3Internal medicine department, Assiut University, Faculty of Medicine, Assiut, Egypt

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by involvement of different organs in the body. The cardiovascular (CVD) involvement in SLE is…
  • Abstract Number: 710 • 2017 ACR/ARHP Annual Meeting

    D-Dimer As an Early Marker in Patients with Lupus Mesenteric Vasculitis

    Xiaolei Ma1, Bingzhu Hua1, Hong Wang1, Yun Zhu1, Zhiyong Chen1 and Lingyun Sun2, 1Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China, 2Department of Rheumatology and Immunology, the Affiliated Drum Tower Hospital, Nanjing University Medical School, nanjing, China

    Background/Purpose: No early serum marker of accurate diagnosis of lupus mesenteric vasculitis (LMV) contributes to the treatment decision-making process. The study was undertaken to evaluate…
  • Abstract Number: 711 • 2017 ACR/ARHP Annual Meeting

    Prevalence and Risk Factors of Depressive Disorders in Chinese Patients with Systemic Lupus Erythematosus (SLE)

    Chi Chiu Mok1, Yan Tung Lilian Lo2, Chi Wai Cheng2 and Kam Shan Poon2, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Psychiatry, Castle Peak Hospital, Hong Kong, Hong Kong

    Background/Purpose: Depression is common in SLE but most previous studies utilized self-rated scales for evaluation. Formal diagnosis of depression was not established by psychiatric interviews.…
  • « Previous Page
  • 1
  • …
  • 1250
  • 1251
  • 1252
  • 1253
  • 1254
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology